The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
Conditions: Relapsed and Refractory B Cell Lymphoma; Non-Hodgkin Lymphoma Intervention: Biological: CD20 CAR-T Sponsor: Shanghai Longyao Biotechnology Inc., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials